• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随访期间身体成分变化对胃肠胰神经内分泌肿瘤生存的影响。

Impact of Change in Body Composition during Follow-Up on the Survival of GEP-NET.

作者信息

Sebastian-Valles Fernando, Sánchez de la Blanca Carrero Nuria, Rodríguez-Laval Víctor, Martinez-Hernández Rebeca, Serrano-Somavilla Ana, Knott-Torcal Carolina, Muñoz de Nova José Luis, Martín-Pérez Elena, Marazuela Mónica, Sampedro-Nuñez Miguel Antonio

机构信息

Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, 28006 Madrid, Spain.

Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa, 28006 Madrid, Spain.

出版信息

Cancers (Basel). 2022 Oct 22;14(21):5189. doi: 10.3390/cancers14215189.

DOI:10.3390/cancers14215189
PMID:36358607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9654293/
Abstract

Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are heterogeneous rare diseases causing malnutrition and cachexia in which the study of body composition may have an impact in prognosis. Aim: Evaluation of muscle and fat tissues by computed tomography (CT) at the level of the third lumbar (L3 level) at diagnosis and at the end of follow-up in GET-NET patients and their relationships with clinical and biochemical variables as predictors of survival. Methodology: Ninety-eight GEP-NET patients were included. Clinical and biochemical parameters were evaluated. Total body, subcutaneous, visceral and total fat areas and very low-density, low-density, normal density, high-density, very high-density and total muscle areas were obtained from CT images. Results: Body composition measures and overall mortality correlated with age, ECOG (Eastern Cooperative Oncology Group performance status) metastases, lactate dehydrogenase (LDH), albumin and urea levels. Although there was no relationship between body composition variables at diagnosis and overall and specific mortality, an increase in low-density muscle and a decrease in normal-density muscle during follow-up were independently correlated to overall (p <0.05) and tumor-cause mortality (p < 0.05). Conclusion: Although body composition measures obtained by CT at diagnosis did not impact survival of GEP-NET patients, a loss of good quality muscle during follow-up was associated with an increased overall and tumor-related mortality. Nutritional status should therefore be supervised by nutrition specialists and an increase in good quality muscle could improve prognosis.

摘要

背景

胃肠胰神经内分泌肿瘤(GEP-NETs)是一种异质性罕见疾病,可导致营养不良和恶病质,其中身体成分的研究可能对预后产生影响。目的:在GEP-NET患者诊断时及随访结束时,通过计算机断层扫描(CT)评估第三腰椎水平(L3水平)的肌肉和脂肪组织,并研究它们与作为生存预测指标的临床和生化变量之间的关系。方法:纳入98例GEP-NET患者。评估临床和生化参数。从CT图像中获取全身、皮下、内脏和总脂肪面积以及极低密度、低密度、正常密度、高密度、极高密度和总肌肉面积。结果:身体成分测量值和总死亡率与年龄、东部肿瘤协作组(ECOG)体力状况、转移情况、乳酸脱氢酶(LDH)、白蛋白和尿素水平相关。虽然诊断时的身体成分变量与总死亡率和特定死亡率之间没有关系,但随访期间低密度肌肉增加和正常密度肌肉减少与总死亡率(p<0.05)和肿瘤相关死亡率(p<0.05)独立相关。结论:虽然诊断时通过CT获得的身体成分测量值对GEP-NET患者的生存没有影响,但随访期间优质肌肉的减少与总死亡率和肿瘤相关死亡率增加有关。因此,营养状况应由营养专家进行监测,增加优质肌肉量可能改善预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/9654293/89ebddc5615e/cancers-14-05189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/9654293/d0fa2632fab0/cancers-14-05189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/9654293/9ae9443be4e3/cancers-14-05189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/9654293/b4fb688afbe0/cancers-14-05189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/9654293/89ebddc5615e/cancers-14-05189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/9654293/d0fa2632fab0/cancers-14-05189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/9654293/9ae9443be4e3/cancers-14-05189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/9654293/b4fb688afbe0/cancers-14-05189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/9654293/89ebddc5615e/cancers-14-05189-g004.jpg

相似文献

1
Impact of Change in Body Composition during Follow-Up on the Survival of GEP-NET.随访期间身体成分变化对胃肠胰神经内分泌肿瘤生存的影响。
Cancers (Basel). 2022 Oct 22;14(21):5189. doi: 10.3390/cancers14215189.
2
Investigating Nutrition-Related Complications and Quality of Life in Patients With Gastroenteropancreatic Neuroendocrine Tumors: Protocol for a Mixed-Methods Prospective Study.胃肠胰神经内分泌肿瘤患者营养相关并发症及生活质量调查:一项混合方法前瞻性研究方案
JMIR Res Protoc. 2018 Dec 19;7(12):e11228. doi: 10.2196/11228.
3
Body composition predictors of mortality on computed tomography in patients with spinal metastases undergoing surgical treatment.在接受手术治疗的脊柱转移瘤患者中,计算机断层扫描(CT)上的身体成分预测死亡率的因素。
Spine J. 2022 Apr;22(4):595-604. doi: 10.1016/j.spinee.2021.10.011. Epub 2021 Oct 23.
4
Nutritional Complications and the Management of Patients with Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤患者的营养并发症及处理
Neuroendocrinology. 2020;110(5):430-442. doi: 10.1159/000503634. Epub 2019 Sep 25.
5
Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness.营养状况对胃肠胰神经内分泌肿瘤(GEP-NET)侵袭性的影响。
Nutrients. 2018 Dec 1;10(12):1854. doi: 10.3390/nu10121854.
6
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.心-代谢指数和代谢综合征作为胃肠胰神经内分泌肿瘤临床严重程度的预测因子。
Front Endocrinol (Lausanne). 2021 Mar 18;12:649496. doi: 10.3389/fendo.2021.649496. eCollection 2021.
7
Prevalence of malnutrition and nutrition-related complications in patients with gastroenteropancreatic neuroendocrine tumours.胃肠胰神经内分泌肿瘤患者的营养不良及营养相关并发症发生率。
J Neuroendocrinol. 2022 Jun;34(6):e13116. doi: 10.1111/jne.13116. Epub 2022 Apr 12.
8
Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.生长抑素受体亚型5的截短剪接变体sst5TMD4的存在与胰腺神经内分泌肿瘤侵袭性增加的特征相关。
Oncotarget. 2016 Feb 9;7(6):6593-608. doi: 10.18632/oncotarget.6565.
9
The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours.全球营养不良标准的领导地位揭示了高比例的营养不良,这影响了胃肠胰腺神经内分泌肿瘤患者的总体生存率。
J Neuroendocrinol. 2024 Apr;36(4):e13376. doi: 10.1111/jne.13376. Epub 2024 Feb 22.
10
Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.美国胃肠胰神经内分泌肿瘤患者总体生存的流行病学趋势及相关因素。
JAMA Netw Open. 2021 Sep 1;4(9):e2124750. doi: 10.1001/jamanetworkopen.2021.24750.

引用本文的文献

1
Association Between Sarcopenia Measured by Computed Tomography at the Third Lumbar Vertebra and Mortality in Inpatients with Delirium Referred to a Liaison Psychiatry Team: A Follow-Up Study.通过第三腰椎计算机断层扫描测量的肌肉减少症与转诊至联络精神科团队的谵妄住院患者死亡率之间的关联:一项随访研究。
J Clin Med. 2025 Jul 17;14(14):5065. doi: 10.3390/jcm14145065.
2
Impact of Sarcopenia on Mortality in Patients Undergoing TAVI: A Follow-Up Study.肌少症对接受经导管主动脉瓣植入术患者死亡率的影响:一项随访研究
J Clin Med. 2025 May 4;14(9):3182. doi: 10.3390/jcm14093182.
3
Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study.

本文引用的文献

1
Nutritional ultrasound®: Conceptualisation, technical considerations and standardisation.营养超声®:概念化、技术考量与标准化
Endocrinol Diabetes Nutr (Engl Ed). 2023 Mar;70 Suppl 1:74-84. doi: 10.1016/j.endien.2022.11.010.
2
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis.依维莫司治疗转移性神经内分泌肿瘤患者时身体成分的预后和预测作用:一项真实世界数据分析
Cancers (Basel). 2022 Jun 30;14(13):3231. doi: 10.3390/cancers14133231.
3
Vitamin D in Osteosarcopenic Obesity.
西班牙晚期胃肠胰神经内分泌肿瘤患者的营养状况与生活质量:NUTRIGETNE(GETNE-S2109)研究
Oncologist. 2025 Feb 6;30(2). doi: 10.1093/oncolo/oyae343.
维生素 D 在肌少脂性肥胖中的作用。
Nutrients. 2022 Apr 26;14(9):1816. doi: 10.3390/nu14091816.
4
Changes in body composition in patients with malignant pleural mesothelioma and the relationship with activity levels and dietary intake.恶性胸膜间皮瘤患者的身体成分变化及其与活动水平和饮食摄入的关系。
Eur J Clin Nutr. 2022 Jul;76(7):979-986. doi: 10.1038/s41430-021-01062-6. Epub 2022 Jan 17.
5
Sarcopenia and Ghrelin System in the Clinical Outcome and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms.肌肉减少症与胃饥饿素系统在胃肠胰神经内分泌肿瘤临床结局及预后中的作用
Cancers (Basel). 2021 Dec 27;14(1):111. doi: 10.3390/cancers14010111.
6
Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.头颈部癌症患者的营养状况和骨骼肌状况:对结局的影响。
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2187-2198. doi: 10.1002/jcsm.12829. Epub 2021 Oct 21.
7
Fibrinogen-to-Albumin Ratio is Associated with All-Cause Mortality in Cancer Patients.纤维蛋白原与白蛋白比值与癌症患者的全因死亡率相关。
Int J Gen Med. 2021 Aug 27;14:4867-4875. doi: 10.2147/IJGM.S322735. eCollection 2021.
8
Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT).在接受肽受体放射性核素治疗(PRRT)的神经内分泌肿瘤(NENs)患者中,计算机断层扫描(CT)定义的肌肉减少症和肌脂肪变性很常见。
Eur J Clin Nutr. 2022 Jan;76(1):143-149. doi: 10.1038/s41430-021-00915-4. Epub 2021 May 13.
9
ESPEN practical guideline: Clinical Nutrition in cancer.ESPEN 实践指南:癌症患者的临床营养。
Clin Nutr. 2021 May;40(5):2898-2913. doi: 10.1016/j.clnu.2021.02.005. Epub 2021 Mar 15.
10
High Pretreatment LDH Predicts Poor Prognosis in Hypopharyngeal Cancer.治疗前高乳酸脱氢酶水平预示下咽癌预后不良。
Front Oncol. 2021 Mar 11;11:641682. doi: 10.3389/fonc.2021.641682. eCollection 2021.